Greenville, NC—Metrics Contract Services is investing $3.5 million in a 15,000-square-foot specialized drug stability storage expansion in Greenville that will triple its current capacity as part of a larger $80 million expansion. It plans to hire 110 scientists and technicians.

Stability storage provides specific environmental conditions for drug substance and drug products meeting International Conference on Harmonisation (ICH) standards. Metrics’ stability chambers are fully validated to meet strict temperature, humidity and uniformity controls. Rooms and chambers are continuously monitored to comply with ICH standards as well as current Good Manufacturing Practices (cGMP).

The $3.5-million stability storage facility is part of planned expansions at the Greenville campus. The parent company of Metrics, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment, including 10-plus new analytical labs and formulation development suites. Metrics also will introduce commercial-scale manufacturing capability including multi-particulate layering, bead-coating fluid bed technology and significantly increased capacity to manufacture highly potent products.

The expanded and improved facilities include engineered solutions to support the handling of potent compounds and to mitigate cross-contamination risks, along with an industry-leading design to meet the various requirements of international regulatory agencies.

Metrics and Mayne Pharma have committed to hiring 110 new scientists, quality assurance specialists and other technicians to support expanded operations, increasing their U.S. workforce by more than a third.

Mayne Pharma is a publicly traded specialty pharmaceutical company listed on the Australian Securities Exchange (ASX: MYX).

www.metricscontractservices.com